Contract Development Services

Jan 31, 2014
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Regis Technologies passes a recent FDA audit with no Form 483 observations.
Nov 02, 2013
Pharmaceutical Technology
Data from BioPlan Associates’ 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production suggest that the interest in disposable devices has begun to extend to biopharma operations beyond basic single-use bags and connectors.
Oct 02, 2013
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.
Sep 11, 2013
Pharmaceutical Technology
By Pharmaceutical Technology Editors
New partnership aims to eliminate months from the typical transition time required to move chemistry from the laboratory into commercial applications.
Sep 04, 2013
PTSM: Pharmaceutical Technology Sourcing and Management
Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.
Sep 02, 2013
Pharmaceutical Technology
Are strategic partnerships in clinical research a model for CMC services?
Sep 01, 2013
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Industry experts share their views on the outsourcing model and the current and future direction of contract chemical API manufacturing.
Aug 02, 2013
Pharmaceutical Technology
Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.
Aug 01, 2013
Pharmaceutical Technology
By Pharmaceutical Technology Editors
External manufacturing plays a crucial role in pharmaceutical companies’ supply strategy. The author examines market trends for the captive and merchant global market for active pharmaceutical ingredients and intermediates.
Aug 01, 2013
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Successful product development and technology transfer between a CMO and the sponsor company requires a multifaceted collaborative approach. The author, Marga Vines from Grifols International, analyzes a project for an injectable drug for which a new drug application was submitted to FDA.
native1_300x100
lorem ipsum